HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer

by Garziera, Marica, Virdone, Saverio, De Mattia, Elena, Scarabel, Lucia, Cecchin, Erika, Polesel, Jerry, D’Andrea, Mario, Pella, Nicoletta, Buonadonna, Angela, Favaretto, Adolfo, Toffoli, Giuseppe
Published in Int J Mol Sci (2017)

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

by Garziera, Marica, Bidoli, Ettore, Cecchin, Erika, Mini, Enrico, Nobili, Stefania, Lonardi, Sara, Buonadonna, Angela, Errante, Domenico, Pella, Nicoletta, D’Andrea, Mario, De Marchi, Francesco, De Paoli, Antonino, Zanusso, Chiara, De Mattia, Elena, Tassi, Renato, Toffoli, Giuseppe
Published in PLoS One (2015)

Molecular classifications of gastric cancers: Novel insights and possible future applications

by Garattini, Silvio Ken, Basile, Debora, Cattaneo, Monica, Fanotto, Valentina, Ongaro, Elena, Bonotto, Marta, Negri, Francesca V, Berenato, Rosa, Ermacora, Paola, Cardellino, Giovanni Gerardo, Giovannoni, Mariella, Pella, Nicoletta, Scartozzi, Mario, Antonuzzo, Lorenzo, Silvestris, Nicola, Fasola, Gianpiero, Aprile, Giuseppe
Published in World J Gastrointest Oncol (2017)

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the S...

by Giampieri, Riccardo, Puzzoni, Marco, Daniele, Bruno, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Pella, Nicoletta, Zampino, Maria Giulia, Sozzi, Pietro, Germano, Domenico, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario
Published in Br J Cancer (2017)

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

by De Mattia, Elena, Dreussi, Eva, Montico, Marcella, Gagno, Sara, Zanusso, Chiara, Quartuccio, Luca, De Vita, Salvatore, Guardascione, Michela, Buonadonna, Angela, D’Andrea, Mario, Pella, Nicoletta, Favaretto, Adolfo, Mini, Enrico, Nobili, Stefania, Romanato, Loredana, Cecchin, Erika, Toffoli, Giuseppe
Published in Front Pharmacol (2018)

The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patien...

by Battaglin, Francesca, Schirripa, Marta, Buggin, Federica, Pietrantonio, Filippo, Morano, Federica, Boscolo, Giorgia, Tonini, Giuseppe, Lutrino, Eufemia Stefania, Lucchetti, Jessica, Salvatore, Lisa, Passardi, Alessandro, Cremolini, Chiara, Arnoldi, Ermenegildo, Scartozzi, Mario, Pella, Nicoletta, Boni, Luca, Bergamo, Francesca, Zagonel, Vittorina, Loupakis, Fotios, Lonardi, Sara
Published in BMC Cancer (2018)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer

by Garattini, Silvio Ken, Basile, Debora, Bonotto, Marta, Ongaro, Elena, Porcu, Luca, Corvaja, Carla, Cattaneo, Monica, Andreotti, Victoria Josephine, Lisanti, Camilla, Bertoli, Elisa, Pelizzari, Giacomo, Iacono, Donatella, Miolo, Gianmaria, Cardellino, Giovanni Gerardo, Buonadonna, Angela, Aprile, Giuseppe, Fasola, Gianpiero, Puglisi, Fabio, Pella, Nicoletta
Published in Cancers (Basel) (2021)

The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer

by Basile, Debora, Garattini, Silvio Ken, Corvaja, Carla, Montico, Marcella, Cortiula, Francesco, Pelizzari, Giacomo, Gerratana, Lorenzo, Audisio, Marco, Lisanti, Camilla, Fanotto, Valentina, Ongaro, Elena, Iacono, Donatella, Cardellino, Giovanni Gerardo, Foltran, Luisa, Pella, Nicoletta, Buonadonna, Angela, Aprile, Giuseppe, Di Maio, Massimo, Fasola, Gianpiero, Puglisi, Fabio
Published in Oncologist (2020)

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Tri...

by Cremolini, Chiara, Rossini, Daniele, Dell’Aquila, Emanuela, Lonardi, Sara, Conca, Elena, Del Re, Marzia, Busico, Adele, Pietrantonio, Filippo, Danesi, Romano, Aprile, Giuseppe, Tamburini, Emiliano, Barone, Carlo, Masi, Gianluca, Pantano, Francesco, Pucci, Francesca, Corsi, Domenico C., Pella, Nicoletta, Bergamo, Francesca, Rofi, Eleonora, Barbara, Cecilia, Falcone, Alfredo, Santini, Daniele
Published in JAMA Oncol (2018)

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

by Basile, Debora, Parnofiello, Annamaria, Vitale, Maria Grazia, Cortiula, Francesco, Gerratana, Lorenzo, Fanotto, Valentina, Lisanti, Camilla, Pelizzari, Giacomo, Ongaro, Elena, Bartoletti, Michele, Garattini, Silvio Ken, Andreotti, Victoria Josephine, Bacco, Anna, Iacono, Donatella, Bonotto, Marta, Casagrande, Mariaelena, Ermacora, Paola, Puglisi, Fabio, Pella, Nicoletta, Fasola, Gianpiero, Aprile, Giuseppe, Cardellino, Giovanni G.
Published in J Cachexia Sarcopenia Muscle (2019)

From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy

by Giampieri, Riccardo, Ziranu, Pina, Daniele, Bruno, Zizzi, Antonio, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Casagrande, Mariaelena, Pella, Nicoletta, Demurtas, Laura, Zampino, Maria Giulia, Sozzi, Pietro, Pusceddu, Valeria, Germano, Domenico, Lai, Eleonora, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Puzzoni, Marco, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario
Published in Cancers (Basel) (2020)

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Francesca, Galli, Fabio, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Bagaloni, Irene, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2019)

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Francesca, Galli, Fabio, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Bagaloni, Irene, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2020)

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Fabio, Giacomini, Elisa, Floriani, Irene, Galli, Francesca, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2014)

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-t...

by Borelli, Beatrice, Moretto, Roberto, Lonardi, Sara, Bonetti, Andrea, Antoniotti, Carlotta, Pietrantonio, Filippo, Masi, Gianluca, Burgio, Valentina, Marmorino, Federica, Salvatore, Lisa, Rossini, Daniele, Zaniboni, Alberto, Zucchelli, Gemma, Martignetti, Angelo, Di Battista, Monica, Pella, Nicoletta, Passardi, Alessandro, Boccaccino, Alessandra, Leone, Francesco, Colombo, Camilla, Granetto, Cristina, Vannini, Francesca, Marsico, Valentina Angela, Martinelli, Erika, Antonuzzo, Lorenzo, Vitello, Stefano, Delliponti, Laura, Boni, Luca, Cremolini, Chiara, Falcone, Alfredo
Published in ESMO Open (2018)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

by Barni, Sandro, Rosati, Gerardo, Lonardi, Sara, Pella, Nicoletta, Banzi, Maria, Zampino, Maria G., Dotti, Katia F., Rimassa, Lorenza, Marchetti, Paolo, Maiello, Evaristo, Artioli, Fabrizio, Ferrari, Daris, Labianca, Roberto, Bidoli, Paolo, Zaniboni, Alberto, Sobrero, Alberto, Iaffaioli, Vincenzo, De Placido, Sabino, Frassineti, Gian Luca, Ciarlo, Andrea, Buonadonna, Angela, Silvestris, Nicola, Piazza, Elena, Pavesi, Lorenzo, Moroni, Mauro, Clerico, Mario, Aglietta, Massimo, Giordani, Paolo, Galli, Francesca, Galli, Fabio, Petrelli, Fausto
Published in Ther Adv Med Oncol (2020)

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer

by Loupakis, Fotios, Biason, Paola, Prete, Alessandra Anna, Cremolini, Chiara, Pietrantonio, Filippo, Pella, Nicoletta, Dell’Aquila, Emanuela, Sperti, Elisa, Zichi, Clizia, Intini, Rossana, Dadduzio, Vincenzo, Schirripa, Marta, Bergamo, Francesca, Antoniotti, Carlotta, Morano, Federica, Cortiula, Francesco, De Maglio, Giovanna, Rimassa, Lorenza, Smiroldo, Valeria, Calvetti, Lorenzo, Aprile, Giuseppe, Salvatore, Lisa, Santini, Daniele, Munari, Giada, Salmaso, Roberta, Guzzardo, Vincenza, Mescoli, Claudia, Lonardi, Sara, Rugge, Massimo, Zagonel, Vittorina, Di Maio, Massimo, Fassan, Matteo
Published in Br J Cancer (2019)